Acetylation-Dependent Histone H2Ax Exchange Suppresses Pathological Senescence Via Mdc1 Degradation
Our cells undergo a process called senescence, a state of arrested growth that plays a complex role in our bodies. Sometimes, it’s beneficial, helping to suppress tumors, but other times, it can be detrimental, contributing to age-related diseases. The key question has been: what determines whether this cellular aging is good or bad?
Recent research has uncovered a fascinating mechanism involving a protein called histone H2AX, which is part of the structures that package our DNA. It turns out that the dynamic exchange of this H2AX protein on our DNA acts like a critical quality control system, influencing the outcome of cellular aging. This exchange is driven by a specific chemical modification called acetylation, where a small molecule is added to H2AX by an enzyme called TIP60, working with another protein called FACT. This modification then triggers the removal of a DNA repair protein called MDC1.
When this intricate exchange pathway is disrupted, MDC1 builds up excessively. This accumulation leads to a less accurate way of repairing damaged DNA, which in turn pushes cells towards a harmful form of aging that could even promote cancer. Essentially, this discovery redefines how we view the movement of proteins on our DNA, showing it’s not just a passive event but an active regulator of how our cells age. These findings offer a new understanding of why cellular aging can have such varied effects and open doors for developing new treatments aimed at improving the quality of aging by influencing these cellular processes.
Source: link to paper